FGF21 and metabolic syndrome: After multivariate logistic regression analysis with Model 1 added with eGFR and UACR, an increased 0.5% risk of the MetS (adjusted OR 1.005, 95% CI 1.001–1.010, P=0.027) was observed for every 1 pg/mL increase in FGF21 (Model 2).